Inhibition of human papillomavirus DNA replication by an E1-derived p80/UAF1-binding peptide

Journal of Virology

Volumn 86, Issue 7, 2012, Pages 3486-3500

  Lehoux, Michaël ^a,b   Fradet Turcotte, Amélie ^a,b   Lussier Price, Mathieu ^b   Omichinski, James G ^b   Archambault, Jacques ^a,b  

^a CLIN RESEARCH INSTITUTE OF MONTREAL   (Canada)

^b UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

GLYCOPROTEIN E1; GLYCOPROTEIN E2; MUTANT PROTEIN; N40 PEPTIDE; PROTEIN INHIBITOR; PROTEIN P80; PROTEIN UAF1; UNCLASSIFIED DRUG; VIRUS DNA; VIRUS PROTEIN;

AMINO ACID SEQUENCE; ANTIVIRAL ACTIVITY; ARTICLE; CHROMATIN IMMUNOPRECIPITATION; CONFOCAL FLUORESCENCE MICROSCOPY; CONTROLLED STUDY; CYTOPLASM; DNA REPLICATION; FEMALE; HUMAN; HUMAN CELL; HUMAN PAPILLOMAVIRUS TYPE 31; INTRANUCLEAR SPACE; MICROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; PROTEIN TARGETING; VIRUS ASSEMBLY; VIRUS INHIBITION; WART VIRUS;

CELL LINE, TUMOR; DNA REPLICATION; DNA-BINDING PROTEINS; DOWN-REGULATION; HUMAN PAPILLOMAVIRUS 31; HUMANS; PAPILLOMAVIRUS INFECTIONS; PEPTIDES; PROTEIN BINDING; PROTEIN STRUCTURE, TERTIARY; PROTEINS; VIRAL PROTEINS;

HUMAN PAPILLOMAVIRUS; HUMAN PAPILLOMAVIRUS TYPES; PAPILLOMAVIRIDAE;

EID: 84861312473     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.07003-11     Document Type: Article

References (66)

1. Androphy EJ, Lowy DR, Schiller JT. 1987. Bovine papillomavirus E2 trans-activating gene product binds to specific sites in papillomavirus DNA. Nature 325:70 -73.
2. Baseman JG, Koutsky LA. 2005. The epidemiology of human papillomavirus infections. J. Clin. Virol. 32(Suppl. 1):S16 -S24.
3. Bernard HU, et al. 2010. Classification of papillomaviruses (PVs) based on 189 PV types and proposal of taxonomic amendments. Virology 401: 70-79.
4. Bochkareva E, et al. 2005. Single-stranded DNA mimicry in the p53 transactivation domain interaction with replication protein A. Proc. Natl. Acad. Sci. U. S. A. 102:15412-15417.
5. Boichuk S, Hu L, Hein J, Gjoerup OV. 2010. Multiple DNA damage signaling and repair pathways deregulated by simian virus 40 large T antigen. J. Virol. 84:8007- 8020.
6. Cho NH, et al. 2004. Inhibition of T cell receptor signal transduction by tyrosine kinase-interacting protein of Herpesvirus saimiri. J. Exp. Med. 200:681- 687.
7. Cho NH, et al. 2006. Association of herpesvirus saimiri tip with lipid raft is essential for downregulation of T-cell receptor and CD4 coreceptor. J. Virol. 80:108 -118.
8. Clower RV, Fisk JC, Melendy T. 2006. Papillomavirus E1 protein binds to and stimulates human topoisomerase I. J. Virol. 80:1584 -1587.
9. Cohn MA, Kee Y, Haas W, Gygi SP, D'Andrea AD. 2009. UAF1 is a subunit of multiple deubiquitinating enzyme complexes. J. Biol. Chem. 284:5343-5351.
10. Cohn MA, et al. 2007. A UAF1-containing multisubunit protein complex regulates the Fanconi anemia pathway. Mol. Cell 28:786 -797.
11. Conger KL, Liu JS, Kuo SR, Chow LT, Wang TS. 1999. Human papillomavirus DNA replication. Interactions between the viral E1 protein and two subunits of human DNA polymerase alpha/primase. J. Biol. Chem. 274:2696 -2705.
12. Cote-Martin A, et al. 2008. Human papillomavirus E1 helicase interacts with the WD repeat protein p80 to promote maintenance of the viral genome in keratinocytes. J. Virol. 82:1271-1283.
13. Daling JR, et al. 2004. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 101:270 -280.
14. Deng W, et al. 2004. Cyclin/CDK regulates the nucleocytoplasmic localization of the human papillomavirus E1DNAhelicase. J. Virol. 78:13954- 13965.
15. de Villiers EM, Fauquet C, Broker TR, Bernard HU, zur Hausen H. 2004. Classification of papillomaviruses. Virology 324:17-27.
16. Di Lello P, et al. 2006. Structure of the Tfb1/p53 complex: insights into the interaction between the p62/Tfb1 subunit of TFIIH and the activation domain of p53. Mol. Cell 22:731-740.
17. Dyson HJ, Wright PE. 2005. Intrinsically unstructured proteins and their functions. Nat. Rev. Mol. Cell Biol. 6:197-208.
18. Fradet-Turcotte A, et al. 2011. Nuclear accumulation of the papillomavirus E1 helicase blocks S-phase progression and triggers an ATMdependent DNA damage response. J. Virol. 85:8996 -9012.
19. Fradet-Turcotte A, Moody C, Laimins LA, Archambault J. 2010. Nuclear export of human papillomavirus type 31 E1 is regulated by Cdk2 phosphorylation and required for viral genome maintenance. J. Virol. 84:11747-11760.
20. Fradet-Turcotte A, Morin G, Lehoux M, Bullock PA, Archambault J. 2010. Development of quantitative and high-throughput assays of polyomavirus and papillomavirus DNA replication. Virology 399:65-76.
21. Frappier L, Verrijzer CP. 2011. Gene expression control by protein deubiquitinases. Curr. Opin. Genet. Dev. 21:207-213.
22. Frattini MG, Laimins LA. 1994. Binding of the human papillomavirus E1 origin-recognition protein is regulated through complex formation with the E2 enhancer-binding protein. Proc. Natl. Acad. Sci. U. S. A. 91:12398- 12402.
23. Frattini MG, Laimins LA. 1994. The role of the E1 and E2 proteins in the replication of human papillomavirus type 31b. Virology 204:799-804.
24. Frisch M, et al. 1999. Variants of squamous cell carcinoma of the anal canal and perianal skin and their relation to human papillomaviruses. Cancer Res. 59:753-757.
25. Han Y, Loo YM, Militello KT, Melendy T. 1999. Interactions of the papovavirus DNA replication initiator proteins, bovine papillomavirus type 1 E1 and simian virus 40 large T antigen, with human replication protein A. J. Virol. 73:4899-4907.
26. Hebner CM, Laimins LA. 2006. Human papillomaviruses: basic mechanisms of pathogenesis and oncogenicity. Rev. Med. Virol. 16:83-97.
27. Huang TT, et al. 2006. Regulation of monoubiquitinated PCNA by DUB autocleavage. Nat. Cell Biol. 8:339 -347.
28. Jonker HR, Wechselberger RW, Boelens R, Folkers GE, Kaptein R. 2005. Structural properties of the promiscuous VP16 activation domain. Biochemistry 44:827- 839.
29. Joo HY, et al. 2011. Regulation of histone H2A and H2B deubiquitination and Xenopus development by USP12 and USP46. J. Biol. Chem. 286: 7190-7201.
30. Kim JM, et al. 2009. Inactivation of murine Usp1 results in genomic instability and a Fanconi anemia phenotype. Dev. Cell 16:314 -320.
31. King LE, et al. 2010. Human papillomavirus E1 and E2 mediated DNA replication is not arrested by DNA damage signalling. Virology 406:95- 102.
32. Kreimer AR, Clifford GM, Boyle P, Franceschi S. 2005. Human papillomavirus types in head and neck squamous cell carcinomas worldwide: a systematic review. Cancer Epidemiol. Biomarkers Prev. 14:467- 475.
33. Lee D, Sohn H, Kalpana GV, Choe J. 1999. Interaction of E1 and hSNF5 proteins stimulates replication of human papillomavirus DNA. Nature 399:487- 491.
34. Lehoux M, D'Abramo CM, Archambault J. 2009. Molecular mechanisms of human papillomavirus-induced carcinogenesis. Public Health Genomics 12:268 -280.
35. Loo YM, Melendy T. 2004. Recruitment of replication protein A by the papillomavirus E1 protein and modulation by single-stranded DNA. J. Virol. 78:1605-1615.
36. Masterson PJ, Stanley MA, Lewis AP, Romanos MA. 1998. A C-terminal helicase domain of the human papillomavirus E1 protein binds E2 and the DNA polymerase alpha-primase p68 subunit. J. Virol. 72:7407-7419.
37. Melendy T, Sedman J, Stenlund A. 1995. Cellular factors required for papillomavirus DNA replication. J. Virol. 69:7857-7867.
38. Metallo SJ. 2010. Intrinsically disordered proteins are potential drug targets. Curr. Opin. Chem. Biol. 14:481- 488.
39. Mohr IJ, et al. 1990. Targeting the E1 replication protein to the papillomavirus origin of replication by complex formation with the E2 transactivator. Science 250:1694 -1699.
40. Moody CA, Laimins LA. 2009. Human papillomaviruses activate the ATM DNA damage pathway for viral genome amplification upon differentiation. PLoS Pathog. 5:e1000605.
41. Morin G, et al. 2011. A conserved amphipathic helix in the N-terminal regulatory region of the papillomavirus E1 helicase is required for efficient viral DNA replication. J. Virol. 85:5287-5300.
42. Nagai T, et al. 2002. A variant of yellow fluorescent protein with fast and efficient maturation for cell-biological applications. Nat. Biotechnol. 20: 87-90.
43. Nijman SM, et al. 2005. The deubiquitinating enzyme USP1 regulates the Fanconi anemia pathway. Mol. Cell 17:331-339.
44. Park J, et al. 2003. Distinct roles of cellular Lck and p80 proteins in herpesvirus saimiri Tip function on lipid rafts. J. Virol. 77:9041-9051.
45. Park J, et al. 2002. Herpesviral protein targets a cellular WD repeat endosomal protein to downregulate T lymphocyte receptor expression. Immunity 17:221-233.
46. Park P, et al. 1994. The cellular DNA polymerase alpha-primase is required for papillomavirusDNAreplication and associates with the viral E1 helicase. Proc. Natl. Acad. Sci. U. S. A. 91:8700-8704.
47. Parkin DM, Bray F, Ferlay J, Pisani P. 2005. Global cancer statistics, 2002. CA Cancer J. Clin. 55:74 -108.
48. Partridge JM, Koutsky LA. 2006. Genital human papillomavirus infection in men. Lancet Infect. Dis. 6:21-31.
49. Sakakibara N, Mitra R, McBride AA. 2011. The papillomavirus E1 helicase activates a cellular DNA damage response in viral replication foci. J. Virol. 85:8981- 8995.
50. Sanchez-Pulido L, Devos D, Sung ZR, Calonje M. 2008. RAWUL: a new ubiquitin-like domain in PRC1 ring finger proteins that unveils putative plant and worm PRC1 orthologs. BMC Genomics 9:308.
51. Sanders CM, Stenlund A. 2001. Mechanism and requirements for bovine papillomavirus, type 1, E1 initiator complex assembly promoted by the E2 transcription factor bound to distal sites. J. Biol. Chem. 276:23689 -23699.
52. Sarkari F, et al. 2009. EBNA1-mediated recruitment of a histone H2B deubiquitylating complex to the Epstein-Barr virus latent origin of DNA replication. PLoS Pathog. 5:e1000624.
53. Schuck S, Stenlund A. 2005. Assembly of a double hexameric helicase. Mol. Cell 20:377-389.
54. Schuck S, Stenlund A. 2005. Role of papillomavirus E1 initiator dimerization in DNA replication. J. Virol. 79:8661- 8664.
55. Senechal H, Poirier GG, Coulombe B, Laimins LA, Archambault J. 2007. Amino acid substitutions that specifically impair the transcriptional activity of papillomavirus E2 affect binding to the long isoform of Brd4. Virology 358:10 -17.
56. Smith TF, Gaitatzes C, Saxena K, Neer EJ. 1999. The WD repeat: a common architecture for diverse functions. Trends Biochem. Sci. 24:181- 185.
57. Sullivan CS, Pipas JM. 2002. T antigens of simian virus 40: molecular chaperones for viral replication and tumorigenesis. Microbiol. Mol. Biol. Rev. 66:179 -202.
58. Swindle CS, Engler JA. 1998. Association of the human papillomavirus type 11 E1 protein with histone H1. J. Virol. 72:1994 -2001.
59. Swindle CS, et al. 1999. Human papillomavirus DNA replication compartments in a transient DNA replication system. J. Virol. 73:1001-1009.
60. Titolo S, et al. 2000. Identification of domains of the human papillomavirus type 11 E1 helicase involved in oligomerization and binding to the viral origin. J. Virol. 74:7349 -7361.
61. Titolo S, et al. 1999. Role of the ATP-binding domain of the human papillomavirus type 11 E1 helicase in E2-dependent binding to the origin. J. Virol. 73:5282-5293.
62. Uesugi M, Nyanguile O, Lu H, Levine AJ, Verdine GL. 1997. Induced alpha helix in the VP16 activation domain upon binding to a human TAF. Science 277:1310 -1313.
63. Weisshart K, et al. 1999. Two regions of simian virus 40 T antigen determine cooperativity of double-hexamer assembly on the viral origin of DNA replication and promote hexamer interactions during bidirectional origin DNA unwinding. J. Virol. 73:2201-2211.
64. Wilson VG, West M, Woytek K, Rangasamy D. 2002. Papillomavirus E1 proteins: form, function, and features. Virus Genes 24:275-290.
65. Wooldridge TR, Laimins LA. 2008. Regulation of human papillomavirus type 31 gene expression during the differentiation-dependent life cycle through histone modifications and transcription factor binding. Virology 374:371-380.
66. Yang K, et al. 2011. Regulation of the Fanconi anemia pathway by a SUMO-like delivery network. Genes Dev. 25:1847-1858.